AB
AVNR

Amalgamated Bank’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Amalgamated Bank’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-18,819
Closed -$319K – 952
2014
Q4 		$319K Buy
18,819
+2,273
+14% +$32K 0.05% 546
2014
Q3 		$197K Buy
16,546
+951
+6% +$6.49K 0.03% 791
2014
Q2 		$88K Buy
15,595
+599
+4% +$2.76K 0.01% 850
2014
Q1 		$55K Sell
14,996
-35
-0.2% -$133 0.01% 818
2013
Q4 		$51K Buy
+15,031
New +$62.1K 0.01% 822

Amalgamated Bank's AVNR Position: Q1 2015 in Review

Amalgamated Bank sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 18,819 shares — an estimated $319K sold.

Amalgamated Bank first reported a position in AVNR in Q4 2013 and held it in 5 quarters. The position peaked at $319K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Amalgamated Bank reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Amalgamated Bank sold 18,819 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $319K.
  • Amalgamated Bank first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2013 and held it in 5 quarters.
  • Amalgamated Bank's AVANIR PHARMACEUTICALS, INC CL A position peaked at $319K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Amalgamated Bank's 13F filing for Q1 2015, filed 22 Apr 2015.